{"id":"NCT02640664","sponsor":"Novartis Pharmaceuticals","briefTitle":"Rainbow Extension Study","officialTitle":"RAINBOW Extension Study: an Extension Study to Evaluate the Long Term Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-06-16","primaryCompletion":"2022-04-21","completion":"2022-04-21","firstPosted":"2015-12-29","resultsPosted":"2023-02-13","lastUpdate":"2023-02-13"},"enrollment":180,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Retinopathy of Prematurity (ROP)"],"interventions":[{"type":"DRUG","name":"Ranibizumab","otherNames":[]}],"arms":[{"label":"Ranibizumab 0.2 mg","type":"EXPERIMENTAL"},{"label":"Ranibizumab 0.1 mg","type":"EXPERIMENTAL"},{"label":"Laser therapy","type":"NO_INTERVENTION"}],"summary":"The purpose of this study was to evaluate the long term efficacy and safety of intravitreal ranibizumab compared with laser ablation therapy in patients who were treated for retinopathy of prematurity (ROP) in the core study CRFB002H2301 (NCT02375971)","primaryOutcome":{"measure":"Visual Acuity (VA) of the Better-seeing Eye at the Participant's Fifth Birthday Visit - Comparison Between Treatment Arms","timeFrame":"at the participant's fifth birthday visit (maximum 5 years and 4 months post core baseline visit)","effectByArm":[{"arm":"Ranibizumab 0.2 mg","deltaMin":66.8,"sd":1.95},{"arm":"Ranibizumab 0.1 mg","deltaMin":64.6,"sd":2},{"arm":"Laser Therapy","deltaMin":62.1,"sd":2.18}],"pValues":[{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":73,"countries":["United States","Austria","Belgium","Croatia","Czechia","Denmark","Egypt","Estonia","France","Germany","Greece","Hungary","India","Italy","Japan","Lithuania","Malaysia","Romania","Russia","Saudi Arabia","Slovakia","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["38638400","34391532"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":61},"commonTop":["Strabismus","Nasopharyngitis","Pyrexia","Myopia","Constipation"]}}